Achieving tolerance modifies cancer susceptibility profiles in liver transplant recipients
Abstract Long‐term survival of transplant recipients is significantly impacted by malignancy. We aimed to determine whether calcineurin inhibitor (CNI)‐treated recipients converted to and weaned off molecular target of rapamycin inhibitor (mTOR‐I) therapy have favorable changes in their molecular pr...
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Article |
| שפה: | English |
| יצא לאור: |
Wiley
2023-02-01
|
| סדרה: | Cancer Medicine |
| גישה מקוונת: | https://doi.org/10.1002/cam4.5271 |